Biotech remains a red-hot area for startup founders and investors. Next-generation gene therapies, precision medicine, using AI and ML for speeding discovery and development of new drugs, and entire new delivery methods. What does the future look like, and how should investors and founders parse the opportunities in this sector? On this episode I talk with Marguerite Hutchison, Kent Hawryluk, and Louis Lehot about these topics and more.